Vesey Street Capital Partners L.L.C. Takes Position in AirSculpt Technologies, Inc. $AIRS

Vesey Street Capital Partners L.L.C. acquired a new stake in AirSculpt Technologies, Inc. (NASDAQ:AIRS) in the 2nd quarter, Holdings Channel.com reports. The institutional investor acquired 30,324,180 shares of the company’s stock, valued at approximately $136,458,810,000. AirSculpt Technologies accounts for about 100.0% of Vesey Street Capital Partners L.L.C.’s investment portfolio, making the stock its largest holding. Vesey Street Capital Partners L.L.C. owned about 0.42% of AirSculpt Technologies at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Larson Financial Group LLC raised its holdings in AirSculpt Technologies by 20.4% during the 3rd quarter. Larson Financial Group LLC now owns 15,137 shares of the company’s stock valued at $121,000 after buying an additional 2,561 shares during the period. Wexford Capital LP boosted its stake in AirSculpt Technologies by 2.6% during the third quarter. Wexford Capital LP now owns 102,614 shares of the company’s stock worth $823,000 after buying an additional 2,614 shares during the period. Rhumbline Advisers boosted its stake in AirSculpt Technologies by 16.1% during the third quarter. Rhumbline Advisers now owns 20,782 shares of the company’s stock worth $167,000 after buying an additional 2,876 shares during the period. Creative Planning increased its position in AirSculpt Technologies by 32.2% during the second quarter. Creative Planning now owns 13,225 shares of the company’s stock valued at $64,000 after acquiring an additional 3,224 shares during the last quarter. Finally, BNP Paribas Financial Markets increased its position in AirSculpt Technologies by 239.5% during the third quarter. BNP Paribas Financial Markets now owns 5,952 shares of the company’s stock valued at $48,000 after acquiring an additional 4,199 shares during the last quarter. Hedge funds and other institutional investors own 91.54% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on AIRS. Leerink Partners set a $4.50 target price on shares of AirSculpt Technologies in a report on Thursday, May 14th. Wall Street Zen cut shares of AirSculpt Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, August 15th. Finally, Weiss Ratings upgraded shares of AirSculpt Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, July 1st. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Reduce” and a consensus target price of $4.50.

AirSculpt Technologies Price Performance

AIRS opened at $2.74 on Friday. The business has a fifty day moving average of $4.29 and a 200 day moving average of $3.56. The stock has a market cap of $197.55 million, a P/E ratio of -15.22 and a beta of 2.33. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.32. AirSculpt Technologies, Inc. has a 52-week low of $1.51 and a 52-week high of $12.00.

AirSculpt Technologies (NASDAQ:AIRS) last released its earnings results on Monday, August 10th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.01). AirSculpt Technologies had a negative return on equity of 5.83% and a negative net margin of 7.79%.The business had revenue of $42.90 million during the quarter, compared to analysts’ expectations of $44.14 million.

AirSculpt Technologies Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.